Macular Degeneration Information
HIV Drug May Treat Macular Degeneration
Researchers from the University of Kentucky in Lexington have found that a class of drugs used to treat HIV/AIDS could possibly be used as a treatment for age-related macular degeneration. Dry macular degeneration accounts for approximately 90 percent of the diagnosed cases of the progressive eye disease and until now there have been no viable treatments for this version of AMD. Several … [Read More...]
Smoking Linked to Macular Degeneration
Individuals who smoke are at a greater risk to develop age-related macular degeneration according to a new study conducted by the John Hopkins University School of Medicine. Macular degeneration or AMD is an eye disease that results in the loss of central vision in those patients suffering from the disease. Damage to the center of the retina eventually leads to blindness and macular … [Read More...]
New Dry Macular Degeneration Drug Being Tested
A potential new drug treatment for Macular Degeneration is being tested for patients suffering from dry macular degeneration. The drug, Glatirmar is hoped to have long-term benefits for patients for those suffering from the degenerative eye disease. Until now there was no drug treatment available for dry AMD. However, glatiramer has been shown to improve the retinal sensitivity and reduce other … [Read More...]
Macular Degeneration Treatment by Injection
There are several macular degeneration treatments that are administered by injection. These are used to treat the most severe form of macular degeneration known as wet macular degeneration. Wet Macular Degeneration occurs when abnormal blood vessels in the eye leak, causing loss of central vision. The primary goal when treating macular degeneration by injection into the eye is to seal off the … [Read More...]
Lucentis Costing Medicare $1 Billion
An analysis of medicare data shows that Lucentis, a treatment for wet macular degeneration is costing Medicare in the United States approximately $1 Billion per year. Researchers and eye care specialists have indicated there are alternatives to Lucentis that can offer dramatic savings for the program. In analysing the claims of more than 880,000 medical professionals, it was discovered that the … [Read More...]
New Eye Treatment Effective for Macular Degeneration
A new treatment for the eye disease macular degeneration is showing great promise in studies. This may potentially lead to new forms of treatment for age-related macular degeneration and could help prevent blindness caused by this degenerative eye disease. Research conducted at the Scripps Research Institute in California has produced great results for a new macular degeneration treatment. The … [Read More...]
Macular Degeneration and Obesity
Research conducted at the Harvard Medical School has revealed that age-related macular degeneration could be made worst by being obesity. Patients suffering from the degenerative eye disease may find that the progression of the disease is caused in part by their current weight. … [Read More...]
Nanosecond Laser Treatment for Dry Macular Degeneration
A new nanosecond laser treatment for dry macular degeneration is being tested at the Australian Centre for Eye Research. It is hoped this new treatment will slow or reverse the effects of dry macular degeneration, one of the most common causes of vision loss in the aging population. In a previous trial of 50 patients, it was shown that this new technique may be effective at slowing the eye … [Read More...]
Lucentis Treatment coming to Cape Breton, Nova Scotia
People diagnosed with wet macular degeneration in the Cape Breton, Nova Scotia area will now have access to lucentis as a treatment option. Premier Darrell Dexter made the announcement indicating that that both Lucentis and Avastin treatments will be made available for people who have Pharmacare in the province. Wet Macular Degeneration is the most severe form of the eye disease that attacks … [Read More...]
Stem Cells Implanted into Patient with Dry Macular Degeneration
Stem cells have become the corner stone of research into providing revolutionary treatments for dry macular degeneration. Continuing its Phase I & Phase II clinical trials, StemCells Inc has transplanted stem cells into its first patient suffering from dry macular degeneration. Macular degeneration is an eye disease more common among people aged 50 and older. According to the National … [Read More...]
Recent Comments